FDA Adds Boxed Warning To Psoriasis Drug
The U.S. Food and Drug Administration has added a boxed warning to the psoriasis drug Raptiva, highlighting the risks of life-threatening infections related to use of the skin disease treatment....To view the full article, register now.
Already a subscriber? Click here to view full article